Stereotactic Radiosurgery for Perioptic Meningiomas: An International, Multicenter Study
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články, multicentrická studie
Grantová podpora
U54 GM104942
NIGMS NIH HHS - United States
PubMed
33475718
PubMed Central
PMC8517876
DOI
10.1093/neuros/nyaa544
PII: 6105224
Knihovny.cz E-zdroje
- Klíčová slova
- Gamma Knife, Outcomes, Perioptic meningioma, Progression-free survival, Stereotactic radiosurgery, Visual outcomes,
- MeSH
- doba přežití bez progrese choroby MeSH
- dospělí MeSH
- internacionalita * MeSH
- lidé středního věku MeSH
- lidé MeSH
- magnetická rezonanční tomografie metody MeSH
- meningeální nádory diagnóza chirurgie MeSH
- meningeom diagnóza chirurgie MeSH
- mladiství MeSH
- mladý dospělý MeSH
- následné studie MeSH
- nervus opticus chirurgie MeSH
- radiochirurgie metody MeSH
- retrospektivní studie MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- výsledek terapie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
BACKGROUND: Stereotactic radiosurgery (SRS) is increasingly used for management of perioptic meningiomas. OBJECTIVE: To study the safety and effectiveness of SRS for perioptic meningiomas. METHODS: From 12 institutions participating in the International Radiosurgery Research Foundation (IRRF), we retrospectively assessed treatment parameters and outcomes following SRS for meningiomas located within 3 mm of the optic apparatus. RESULTS: A total of 438 patients (median age 51 yr) underwent SRS for histologically confirmed (29%) or radiologically suspected (71%) perioptic meningiomas. Median treatment volume was 8.01 cm3. Median prescription dose was 12 Gy, and median dose to the optic apparatus was 8.50 Gy. A total of 405 patients (93%) underwent single-fraction SRS and 33 patients (7%) underwent hypofractionated SRS. During median imaging follow-up of 55.6 mo (range: 3.15-239 mo), 33 (8%) patients experienced tumor progression. Actuarial 5-yr and 10-yr progression-free survival was 96% and 89%, respectively. Prescription dose of ≥12 Gy (HR: 0.310; 95% CI [0.141-0.679], P = .003) and single-fraction SRS (HR: 0.078; 95% CI [0.016-0.395], P = .002) were associated with improved tumor control. A total of 31 (10%) patients experienced visual decline, with actuarial 5-yr and 10-yr post-SRS visual decline rates of 9% and 21%, respectively. Maximum dose to the optic apparatus ≥10 Gy (HR = 2.370; 95% CI [1.086-5.172], P = .03) and tumor progression (HR = 4.340; 95% CI [2.070-9.097], P < .001) were independent predictors of post-SRS visual decline. CONCLUSION: SRS provides durable tumor control and quite acceptable rates of vision preservation in perioptic meningiomas. Margin dose of ≥12 Gy is associated with improved tumor control, while a dose to the optic apparatus of ≥10 Gy and tumor progression are associated with post-SRS visual decline.
Centro Gamma Knife Dominicano and CEDIMAT Radiology Department Santo Domingo Dominican Republic
Clinical Oncology Department Ain Shams University Cairo Egypt
Department of Neurosurgery Humanitas Clinical and Research Center IRCCS Milan Italy
Department of Neurosurgery Neurological Institute Taipei Veteran General Hospital Taipei Taiwan
Department of Neurosurgery University of Southern California Los Angeles California
Department of Neurosurgery University of Virginia Charlottesville Virginia
Department of Neurosurgery West Virginia University Morgantown West Virginia
Department of Radiation Oncology University of Colorado Denver Colorado
Department of Radiation Oncology University of Southern California Los Angeles California
Department of Radiation Oncology West Virginia University Morgantown West Virginia
Division of Radiation Oncology Department of Oncology University of Alberta Edmonton Canada
Gamma Knife Center Cairo Nasser Institute Hospital Cairo Egypt
Gamma Knife Center Jewish Hospital Mayfield Clinic Cincinnati Ohio
Neurosurgery Department Ain Shams University Cairo Egypt
Neurosurgery Department Benha University Qalubya Egypt
Radiation Oncology Department National Cancer Institute Cairo University Giza Egypt
School of Medicine National Yang Ming University Taipei Taiwan
Stereotactic and Radiation Neurosurgery Department Na Homolce Hospital Prague Czech Republic
Zobrazit více v PubMed
Eddleman CS, Liu JK. Optic nerve sheath meningioma: current diagnosis and treatment. Neurosurg Focus. 2007;23(5):E4. PubMed
Risi P, Uske A, de Tribolet N. Meningiomas involving the anterior clinoid process. Br J Neurosurg. 1994;8(3):295-305. PubMed
Hayhurst C, Teo C. Tuberculum sella meningioma. Otolaryngol Clin North Am. 2011;44(4):953-963. PubMed
Al-Mefty O. Clinoidal meningiomas. J Neurosurg. 1990;73(6):840-849. PubMed
Talacchi A, Hasanbelliu A, D’Amico Aet al. . Long-term follow-up after surgical removal of meningioma of the inner third of the sphenoidal wing: outcome determinants and different strategies. Neurosurg Rev. 2020;43(1):109-117. PubMed
Magill ST, Morshed RA, Lucas C-HGet al. . Tuberculum sellae meningiomas: grading scale to assess surgical outcomes using the transcranial versus transsphenoidal approach. Neurosurg Focus. 2018;44(4):E9. PubMed
Marchetti M, Conti A, Beltramo Get al. . Multisession radiosurgery for perioptic meningiomas: medium-to-long term results from a CyberKnife cooperative study. J Neurooncol. 2019;143(3):597-604. PubMed
Pechlivanis I, Wawrzyniak S, Engelhardt M, Schmieder K. Evidence level in the treatment of meningioma with focus on the comparison between surgery versus radiotherapy. A review. J Neurosurg Sci. 2011;55(4):319-328. PubMed
Schick U, Dott U, Hassler W. Surgical management of meningiomas involving the optic nerve sheath. J Neurosurg. 2004;101(6):951-959. PubMed
Bassiouni H, Asgari S, Sandalcioglu IE, Seifert V, Stolke D, Marquardt G. Anterior clinoidal meningiomas: functional outcome after microsurgical resection in a consecutive series of 106 patients: clinical article. J Neurosurg. 2009;111(5):1078-1090. PubMed
Giammattei L, Starnoni D, Levivier M, Messerer M, Daniel RT. Surgery for clinoidal meningiomas: case series and meta-analysis of outcomes and complications. World Neurosurg. 2019;129:e700-e717. PubMed
Taha ANM, Erkmen K, Dunn IF, Pravdenkova S, Al-Mefty O. Meningiomas involving the optic canal: pattern of involvement and implications for surgical technique. Neurosurg Focus. 2011;30(5):E12. PubMed
Adler JR, Gibbs IC, Puataweepong P, Chang SD. Visual field preservation after multisession CyberKnife radiosurgery for perioptic lesions. Neurosurgery. 2006;59(2):244-254; discussion 244-254. PubMed
Dufour H, Muracciole X, Métellus P, Régis J, Chinot O, Grisoli F. Long-term tumor control and functional outcome in patients with cavernous sinus meningiomas treated by radiotherapy with or without previous surgery: is there an alternative to aggressive tumor removal? Neurosurgery. 2001;48(2):285-294; discussion 294-296. PubMed
Cohen-Inbar O, Lee C, Schlesinger D, Xu Z, Sheehan JP. Long-term results of stereotactic radiosurgery for skull base meningiomas. Neurosurgery. 2016;79(1):58-68. PubMed
Kondziolka D, Mathieu D, Lunsford LDet al. . Radiosurgery as definitive management of intracranial meningiomas. Neurosurgery. 2008;62(1):53-60; discussion 58-60. PubMed
Minniti G, Amichetti M, Enrici RM. Radiotherapy and radiosurgery for benign skull base meningiomas. Radiat Oncol. 2009;4(1):42. PubMed PMC
Stafford SL, Pollock BE, Leavitt JAet al. . A study on the radiation tolerance of the optic nerves and chiasm after stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2003;55(5):1177-1181. PubMed
Milano MT, Grimm J, Soltys SGet al. . Single- and multi-fraction stereotactic radiosurgery dose tolerances of the optic pathways. Int J Radiat Oncol Biol Phys. published online: 2018. (doi:10.1016/j.ijrobp.2018.01.053). PubMed PMC
Conti A, Pontoriero A, Midili Fet al. . CyberKnife multisession stereotactic radiosurgery and hypofractionated stereotactic radiotherapy for perioptic meningiomas: intermediate-term results and radiobiological considerations. Springerplus. 2015;4:37. PubMed PMC
Bunevicius A, Kano H, Lee C-Cet al. . Early versus late Gamma Knife radiosurgery for Cushing's disease after prior resection: results of an international, multicenter study. J Neurosurg. published online: February 21, 2020. (doi:10.3171/2019.12.JNS192836). PubMed
El-Shehaby AMN, Reda WA, Abdel Karim KM, Emad Eldin RM, Nabeel AM. Single-session Gamma Knife radiosurgery for optic pathway/hypothalamic gliomas. J Neurosurg. 2016;125(Suppl_1):50-57. PubMed
Kim M-S, Park K, Kim JH, Kim Y-D, Lee J-I. Gamma Knife radiosurgery for orbital tumors. Clin Neurol Neurosurg. 2008;110(10):1003-1007. PubMed
Akyoldaş G, Hergünsel ÖB, Yılmaz M, Şengöz M, Peker S. Gamma Knife radiosurgery for anterior clinoid process meningiomas: a series of 61 consecutive patients. World Neurosurg. 2020;133:e529-e534. PubMed
Sheehan JP, Starke RM, Kano Het al. . Gamma Knife radiosurgery for sellar and parasellar meningiomas: a multicenter study. J Neurosurg. 2014;120(6):1268-1277. PubMed
Vernimmen F, Slabbert JP.. Assessment of the alpha/beta ratios for arteriovenous malformations, meningiomas, acoustic neuromas, and the optic chiasma. Int J Radiat Biol. 2010;86(6):486-498. PubMed
Shrieve DC, Hazard L, Boucher K, Jensen RL. Dose fractionation in stereotactic radiotherapy for parasellar meningiomas: radiobiological considerations of efficacy and optic nerve tolerance. J Neurosurg. 2004;101(Suppl 3):390-395. PubMed
Yang D-Y, Sheehan J, Liu Y-Set al. . Analysis of factors associated with volumetric data errors in Gamma Knife radiosurgery. Stereotact Funct Neurosurg. 2009;87(1):1-7. PubMed
Chukwueke UN, Wen PY.. Use of the Response Assessment in Neuro-Oncology (RANO) criteria in clinical trials and clinical practice. CNS Oncol. 2019;8(1):CNS28. PubMed PMC
Shaw E, Scott C, Souhami Let al. . Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys. 2000;47(2):291-298. PubMed
Sheehan JP, Williams BJ, Yen CP. Stereotactic radiosurgery for WHO grade I meningiomas. J Neurooncol. 2010;99(3):407-416. PubMed
Ganz JC, Backlund E-O, Thorsen FA. The results of Gamma Knife surgery of meningiomas, related to size of tumor and dose. Stereotact Funct Neurosurg. 1993;61(Suppl 1):23-29. PubMed
Meniai-Merzouki F, Bernier-Chastagner V, Geffrelot Jet al. . Hypofractionated Stereotactic Radiotherapy for patients with intracranial meningiomas: impact of radiotherapy regimen on local control. Sci Rep. 2018;8(1):1-8. PubMed PMC
Vera E, Iorgulescu JB, Raper DMSet al. . A review of stereotactic radiosurgery practice in the management of skull base meningiomas. J Neurol Surg B Skull Base. 2014;75(3):152-158. PubMed PMC
Lee C-C, Trifiletti DM, Sahgal Aet al. . Stereotactic Radiosurgery for benign (World Health Organization grade I) cavernous sinus meningiomas—International Stereotactic Radiosurgery Society (ISRS) practice guideline: a systematic review. Neurosurgery. 2018;83(6):1128-1142. PubMed
Cohen-Inbar O, Lee C-C, Sheehan JP. The contemporary role of stereotactic radiosurgery in the treatment of meningiomas. Neurosurg Clin N Am. 2016;27(2):215-228. PubMed
Ding D, Starke RM, Hantzmon J, Yen C-P, Williams BJ, Sheehan JP. The role of radiosurgery in the management of WHO grade II and III intracranial meningiomas. Neurosurg Focus. 2013;35(6):E16. PubMed
Garcia-Barros M, Paris F, Cordon-Cardo Cet al. . Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science. 2003;300(5622):1155-1159. PubMed
Nagle PW, Hosper NA, Barazzuol Let al. . Lack of DNA damage response at low radiation doses in adult stem cells contributes to organ dysfunction. Clin Cancer Res. 2018;24(24):6583-6593. PubMed
Barnett GH, Linskey ME, Adler JRet al. . Stereotactic radiosurgery—an organized neurosurgery-sanctioned definition. J Neurosurg. 2007;106(1):1-5. PubMed
Nguyen JH, Chen C-J, Lee C-Cet al. . Multisession Gamma Knife radiosurgery: a preliminary experience with a noninvasive, relocatable frame. World Neurosurg. 2014;82(6):1256-1263. PubMed
Timmerman RD. An overview of hypofractionation and introduction to this issue of seminars in radiation oncology. Semin Radiat Oncol. 2008;18(4):215-222. PubMed
Bloch O, Sun M, Kaur G, Barani IJ, Parsa AT. Fractionated radiotherapy for optic nerve sheath meningiomas. J Clin Neurosci. 2012;19(9):1210-1215. PubMed
Onodera S, Aoyama H, Katoh Net al. . Long-term outcomes of fractionated stereotactic radiotherapy for intracranial skull base benign meningiomas in single institution. Jpn J Clin Oncol. 2011;41(4):462-468. PubMed
Milker-Zabel S, Zabel A, Schulz-Ertner D, Schlegel W, Wannenmacher M, Debus J. Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors. Int J Radiat Oncol Biol Phys. 2005;61(3):809-816. PubMed
Soldà F, Wharram B, De Ieso PB, Bonner J, Ashley S, Brada M. Long-term efficacy of fractionated radiotherapy for benign meningiomas. Radiother Oncol. 2013;109(2):330-334. PubMed
Kiehna EN, Mulhern RK, Li C, Xiong X, Merchant TE. Changes in attentional performance of children and young adults with localized primary brain tumors after conformal radiation therapy. J Clin Oncol. 2006;24(33):5283-5290. PubMed
Jalali R, Gupta T, Goda JSet al. . Efficacy of stereotactic conformal radiotherapy vs conventional radiotherapy on benign and low-grade brain tumors: a randomized clinical trial. JAMA Oncol. 2017;3(10):1368-1376. PubMed PMC
Haddy N, Mousannif A, Tukenova Met al. . Relationship between the brain radiation dose for the treatment of childhood cancer and the risk of long-term cerebrovascular mortality. Brain. 2011;134(5):1362-1372. PubMed
Appelman-Dijkstra NM, Kokshoorn NE, Dekkers OMet al. . Pituitary dysfunction in adult patients after cranial radiotherapy: systematic review and meta-analysis. J Clin Endocrinol Metab. 2011;96(8):2330-2340. PubMed PMC
Chung CS, Yock TI, Nelson K, Xu Y, Keating NL, Tarbell NJ. Incidence of second malignancies among patients treated with proton versus photon radiation. Int J Radiat Oncol Biol Phys. 2013;87(1):46-52. PubMed
Leavitt JA, Stafford SL, Link MJ, Pollock BE. Long-term evaluation of radiation-induced optic neuropathy after single-fraction stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2013;87(3):524-527. PubMed
Bunevicius A, Sheehan D, Lee Vance M, Schlesinger D, Sheehan JP. Outcomes of Cushing's disease following Gamma Knife radiosurgery: effect of a center's growing experience and era of treatment. J Neurosurg. published online:January 31, 2020. (doi:10.3171/2019.12.JNS192743). PubMed
Speckter H, Santana J, Miches Iet al. . Assessment of the alpha/beta ratio of the optic pathway to adjust hypofractionated stereotactic radiosurgery regimens for perioptic lesions. J Radiat Oncol. 2019;8(3):279-289.